Literature DB >> 12668261

Human cytomegalovirus infection in human renal arteries in vitro.

Barbara Reinhardt1, Bianca Vaida, Rainer Voisard, Lutz Keller, Jürgen Breul, Harald Metzger, Tina Herter, Regine Baur, Anke Lüske, Thomas Mertens.   

Abstract

Studies with animal cytomegaloviruses, epidemiological data from humans as well as in vitro studies suggest the involvement of the human cytomegalovirus (HCMV) in the development of atherosclerosis. Cell culture systems are insufficient for examination of the entire pathogenetic process and a satisfactory animal model for HCMV is not available. An organ culture model was established for HCMV infection of human renal arteries in vitro. After infection with three representative HCMV strains, infectious virus was recovered from supernatants until 144 days post-infection with a peak around day 30 due to a long-lasting productive HCMV infection in still vital cells. Differences in cell tropism and kinetics of infection were identified between the HCMV strains. Specifically, differences in infecting endothelial cells and virus penetration into the lamina media were observed. In infected artery segments, but also in some non-infected arteries from seropositive donors, HCMV DNA could be localized by in situ PCR. Nevertheless, HCMV early antigen was detected by immunohistochemistry exclusively in artery segments infected in vitro. The new organ culture model will permit the study of functional and molecular consequences of HCMV infection in a more physiological micro-environment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668261     DOI: 10.1016/s0166-0934(03)00035-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Pneumonitis in human cytomegalovirus infection.

Authors:  Erik Langhoff; Robert E Siegel
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

2.  Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Authors:  Yiska Weisblum; Amos Panet; Zichria Zakay-Rones; Ronit Haimov-Kochman; Debra Goldman-Wohl; Ilana Ariel; Haya Falk; Shira Natanson-Yaron; Miri D Goldberg; Ronit Gilad; Nell S Lurain; Caryn Greenfield; Simcha Yagel; Dana G Wolf
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

3.  Human Cytomegalovirus Interactions with the Basement Membrane Protein Nidogen 1.

Authors:  Man I Kuan; Hannah K Jaeger; Onesmo B Balemba; John M O'Dowd; Deborah Duricka; Holger Hannemann; Emmerentia Marx; Natacha Teissier; Liliana Gabrielli; Maria Paola Bonasoni; Elizabeth M Keithley; Elizabeth A Fortunato
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 4.  Virus vasculopathy and stroke: an under-recognized cause and treatment target.

Authors:  M A Nagel; R Mahalingam; R J Cohrs; D Gilden
Journal:  Infect Disord Drug Targets       Date:  2010-04

Review 5.  Human cytomegalovirus infection and coronary heart disease: a systematic review.

Authors:  Yu Du; Guangxue Zhang; Zhijun Liu
Journal:  Virol J       Date:  2018-02-06       Impact factor: 4.099

6.  A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population.

Authors:  Silvia Lee; Emily Brook; Jacquita Affandi; Prue Howson; Selita Agnes Tanudjaja; Satvinder Dhaliwal; Ashley Irish; Patricia Price
Journal:  Clin Transl Immunology       Date:  2019-02-11

7.  HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia.

Authors:  Rainer Voisard; Tanja Krügers; Barbara Reinhardt; Bianca Vaida; Regine Baur; Tina Herter; Anke Lüske; Dorothea Weckermann; Karl Weingärtner; Wolfgang Rössler; Vinzenz Hombach; Thomas Mertens
Journal:  BMC Microbiol       Date:  2007-07-20       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.